Viewing Study NCT04525157


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-01 @ 8:33 PM
Study NCT ID: NCT04525157
Status: COMPLETED
Last Update Posted: 2023-09-22
First Post: 2020-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
Sponsor: Clinuvel Pharmaceuticals Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06-06
Start Date Type: ACTUAL
Primary Completion Date: 2016-02-02
Primary Completion Date Type: ACTUAL
Completion Date: 2016-06-06
Completion Date Type: ACTUAL
First Submit Date: 2020-08-06
First Submit QC Date: None
Study First Post Date: 2020-08-25
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-04-29
Results First Submit QC Date: None
Results First Post Date: 2021-05-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-20
Last Update Post Date: 2023-09-22
Last Update Post Date Type: ACTUAL